Identification of a tumor marker chromosome by flow sorting, DNA amplification in vitro, and in situ hybridization of the amplified product
β Scribed by Gert A. Boschman; Charles H. C. M. Buys; Anneke Y. Van Der Veen; Wim Rens; Jan Osinga; Rosalyn M. Slater; Jacob A. Aten
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 605 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
β¦ Synopsis
A method combining flow sorting and molecular cytogenetic techniques for the identification of unknown marker chrornosomes is described. In this study, the bladder tumor cell line 182 was used, which was known t o carry a marker chromosome of the size of chromosome 7 in every cell. From the cytogenetic analysis of Q-banded rnetaphase cells, it was shown to be composed of -40% presumably the greater part of chromosome 20 and for the rest microscopically unidentifiable material.
π SIMILAR VOLUMES
A procedure for amplifying and detecting nucleic acid sequences in situ using cells in suspension and flow cytometry has been developed. The process involves the use of the polymerase chain reaction (PCR) and a fluorescent in situ hybridization (FISH) protocol developed in our laboratory to detect t
## Abstract Previously, this laboratory reported on the development of a flow cytometryβbased method that automates the assessment of the mitotic index (MI) and numerical chromosome changes in chemically treated cultures of human lymphocytes [Muehlbauer PA and Schuler MJ, 2003, 2005]. With this met
Paclitaxel is a recent chemotherapeutic agent that inhibits tubulin depolymerization in tumoral cells. Despite its increasing use against various human cancers, the genotoxicity of paclitaxel has never been studied on normal human cells. The in vitro genotoxic effects of the drug were evaluated with